Suchergebnisse - "Teulé, Alex"

PubPharm (28)

1

Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets : experience of a comprehensive cancer centre network

enthalten in: Molecular oncology | 2023

von Mulet Margalef, N. | Castillo, C. | Mosteiro, M. | +20

2

Mosaicism in PTEN-new case and comment on the literature

enthalten in: European journal of human genetics : EJHG | 2022

von Rofes, P. | Teulé, �. | Feliubadaló, L. | +9

3

Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors : The GETNE-1408 Trial

enthalten in: The oncologist | 2021

von Grande, E. | Rodriguez-Antona, C. | López, C. | +13

4

The predictive ability of the 313 variant-based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant

enthalten in: Genetics in medicine : official journal of the American College of Medical Genetics | 2021

von Lakeman, I. | van den Broek, A. | Vos, J. | +98

5

BARD1 Pathogenic Variants are Associated with Triple-Negative Breast Cancer in a Spanish Hereditary Breast and Ovarian Cancer Cohort

enthalten in: Genes | 2021

von Rofes, P. | Del Valle, J. | Torres-Esquius, S. | +16

6

Comprehensive analysis and ACMG-based classification of CHEK2 variants in hereditary cancer patients

enthalten in: Human mutation | 2020

von Vargas-Parra, G. | Del Valle, J. | Rofes, P. | +22

7

Improving Genetic Testing in Hereditary Cancer by RNA Analysis : Tools to Prioritize Splicing Studies and Challenges in Applying American College of Medical Genetics and Genomics Guidelines

enthalten in: The Journal of molecular diagnostics : JMD | 2020

von Rofes, P. | Menéndez, M. | González, S. | +13

8

ERCC3, a new ovarian cancer susceptibility gene?

enthalten in: European journal of cancer (Oxford, England : 1990) | 2020

von Stradella, A. | Del Valle, J. | Rofes, P. | +16

CommentIn: Eur J Cancer. 2021 Jun;150:281-282. - PMID 33888390

9

The PALBONET Trial : A Phase II Study of Palbociclib in Metastatic Grade 1 and 2 Pancreatic Neuroendocrine Tumors (GETNE-1407)

enthalten in: The oncologist | 2020

von Grande, E. | Teulé, A. | Alonso-Gordoa, T. | +15

CommentIn: Oncologist. 2020 Aug;25(8):e1257-e1258. - PMID 32436279

10

High Prevalence of Somatic Oncogenic Driver Alterations in Patients With NSCLC and Li-Fraumeni Syndrome

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2020

von Mezquita, L. | Jové, M. | Nadal, E. | +28